RxDoctor Payments Data

Thong Pham, MD

Clinical Cardiac Electrophysiology · Sioux City, IANPI 1538188057

Payments from drug & device makers

What this record shows

Medtronic accounts for 71.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2024 at $2,209 and has fallen 92.3% since, to $169 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in IA, where the typical reported total is $15,103.

$3,069in general payments, 2019–2025

Across 72 payments — averaging $42.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Biosense Webster, Inc.$293
  • Pfizer$137
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$85
  • E.r. Squibb & Sons, L.L.C.$74
  • Novartis$50
  • plus $235 from 8 others

What the payments were for

  • Travel & lodging$1,44247%
  • Food & beverage$1,62753%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,069 in reported general payments places this provider in the 25th percentile of 42 clinical cardiac electrophysiology providers in Iowa.

See all clinical cardiac electrophysiology providers in Iowa

Medicare billing

Part B allowed, 2024
$153,822
Medicare patients
4,432
Services billed
8,718

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban249$184,376
XareltoRivaroxaban156$89,837
EntrestoSacubitril/Valsartan24$31,041
Amiodarone Hcl369$3,402
SotalolSotalol Hcl187$1,598
Metoprolol Succinate209$1,177
Midodrine Hcl14$803
Losartan Potassium56$392
Digoxin14$285
Atorvastatin Calcium62$220
Carvedilol51$220
Isosorbide Mononitrate ErIsosorbide Mononitrate13$214
Levothyroxine Sodium81$181
Hydralazine Hcl27$132
Rosuvastatin Calcium22$131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$137$184,376249 claims
Johnson & JohnsonXarelto$43$89,837156 claims
NovartisEntresto$50$31,04124 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 42 clinical cardiac electrophysiology providers in Iowa.

Other clinical cardiac electrophysiology in Sioux City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →